Bon Secours Mercy Health to Buy Surgery Partners for $6 Billion 10-28-26
The Becker Business Report: Private Equity and BusinessSummary
Mercy Bon Secours announces its acquisition of Surgery Partners for approximately $6 billion, marking a significant shift in the healthcare landscape. This move reflects a growing trend among health systems to expand their operations beyond traditional hospital settings into ambulatory care. Surgery Partners is recognized as one of the largest operators of surgery centers and same-day hospitals in the United States.
This acquisition follows similar transactions in the industry, including Ascension's purchase of Amsurge and Tenet Healthcare's acquisition of United Surgical Partners. The leadership at Surgery Partners, including CEO Eric Evans and COO Justin Oppenheim, has been credited with steering the company in a positive direction in recent years, making the acquisition particularly noteworthy within the context of evolving healthcare strategies.
The deal underscores Mercy Bon Secours' commitment to enhancing its service offerings and adapting to the changing demands of the healthcare market.
Show Notes
In this episode, Scott Becker examines Mercy Bon Secours’ proposed $6 billion acquisition of Surgery Partners and how major health systems, including Ascension and Tenet, are expanding their surgery center investments to evolve their business models.
More from The Becker Business Report: Private Equity and Business
In this episode, Scott Becker explores how key mentors, colleagues, and supporters can have an outsized impact on career growth, confidence, and professional opportunities.
In this episode, Scott Becker covers the latest market gains, Boeing’s narrowing losses despite ongoing challenges, and Netflix’s year to date stock decline.
In this episode, Scott Becker shares 10 principles for driving business growth through niche markets, targeted outbound sales, customer relationships, customer service, and effective sales team development.
In this episode, Scott Becker discusses Apple’s market growth and new iPhone demand, SpaceX’s $40 billion debt deal to fund AI ambitions, and Meta’s recent stock decline and $35 billion AI funding plans.
In this episode, Phoebe L. Yang. a former C-suite executive across four public companies, an appointee in two Presidential Administrations, and a Fortune 250/S&P 500 board director (GE HealthCare, Doximity, CommonSpirit Health, JudiHealth), most recently General Manager of Amazon Web Services Healthcare, and faculty of Stanford Law School, where she designed and teaches a popular […]